[Skip to Content]

fluocinolone

NICE rapid review of the use of fluocinolone acetonide for chronic DMO

College Statment Since the release of TA 2711 in January 2013, NICE has undertaken a rapid review of the use of fluocinolone acetonide for chronic diabetic macular oedema2 and has recently released the FAD document for this single technology appraisal3. In the FAD document, the following guidance has been issued: Fluocinolone acetonide intravitreal implant is